CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 214 enrolled
Drug / intervention
Vancomycin +1 moredrug
Likely dose
Vancomycin 10 mLfrom record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT00915967
NCT00915967N/ACompleted
CompareCT.gov

Pilot Project: Prevention of Neurosurgical Wound Infections

Oregon Health and Science University·interventional·Posted Jun 8, 2009·Updated Apr 30, 2019

In Brief

A clinical study evaluating Vancomycin and Placebo (Saline Solution) for Surgical Wound Infections. Completed, enrolled 214 participants across 1 site.

Detailed Summary

The goal of this study is to determine whether injecting the antibiotic vancomycin directly into surgical wounds can decrease the rate of infection following implantation of neurosurgical devices.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsSurgical Wound Infections
CountriesUnited States
Collaborators--

Timeline

N/ACompletedFinished
200920102011201220132014201520162017201820192020202120222023202420252026
First PostedJun 8, 2009
Enrollment StartMay 13, 2009
Primary CompletionDec 19, 2014
TodayJul 2, 2026
Enrollment to primary: 5.6 yearsPosted 17.1 years ago

Interventions

Vancomycindrug

Subjects randomized to the vancomycin group will receive an injection (up to 10 mL) of 5 mg/mL vancomycin administered directly into the wound with a blunt needle following watertight fascial closure.

Placebo (Saline Solution)drug

Subjects randomized to the saline group will receive an injection (up to 10 mL) of saline solution directly into the wound following watertight fascial closure.